CLINICAL AND PHARMACOKINETIC (PK) RESULTS OF 4 PHASE-I STUDIES OF THE2ND-GENERATION MATRIX METALLOPROTEASE (MMP) INHIBITOR BAY-12-9566, A NONPEPTIDIC BIPHENYL INHIBITOR OF MMPS-2, MMPS-3 AND MMPS-9
L. Seymour et al., CLINICAL AND PHARMACOKINETIC (PK) RESULTS OF 4 PHASE-I STUDIES OF THE2ND-GENERATION MATRIX METALLOPROTEASE (MMP) INHIBITOR BAY-12-9566, A NONPEPTIDIC BIPHENYL INHIBITOR OF MMPS-2, MMPS-3 AND MMPS-9, Annals of oncology, 9, 1998, pp. 601-601